Bull therapy 101-thread for technical analysis with the fundamentals

[Dev_S]

Biocon - weekly breakout with volumes, strong Q3 performance and commentary by Biologics biz

Biocon - The ultimate biosimilars play!

Biocon Q3 show was strong on all fronts, 2nd consecutive quarter of strong performance by Biologics and signs of generic turnaround, outlook commentary good as well, Q3 concall a must listen for understanding direction better [Biocon Earnings Call for Q3FY22] Key highlights from concall Q3 21 2200 cr revenue, pbt reported at 269 cr = 350 cr excluding mtm losses for Adagio - annualized 8-9K cr revenue, 1400 to 1500 cr pbt. PAT in range of 1200cr+ range per mgmt estimations …